About me

Research Associate Professor of Medicine (Translational Medicine and Human Genetics)

Spoken languages

English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Dr. Cuchel is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Yang G, Zhang DY, Fischman CJ, Cuchel M, Susztak K, Rader DJ. The Role of Angiopoietin-Like Proteins 3 and 4 and Their Target Lipases in CKD: A Drug-Target Mendelian Randomization Study , Am J Kidney Dis: 2026

Bajaj A, Cuchel M. Lowering cumulative LDL-C exposure: the case for early treatment , Eur Heart J: 2026

Cohen S, Hudgins LC, Freiberger T, Gallo A, Groselj U, Al-Khnifsawi M, Khovidhunkit W, Raal FJ, Roeters van Lennep JE, Wiegman A, Mueller R, Cuchel M. Real-World Practices for Management of Very Young Patients with Homozygous Familial Hypercholesterolemia: A Clinician Survey , European Atherosclerotic society Congress 2026, Athens, Greece: 2026

Schonck WAM, Mulder JWCM, Cuchel M, Reeskamp LF, Alnouri F, Iatan I, Freiberger T, Kayıkçıoğlu M, Tromp TR, Reijman MD, Wiegman A, Hovingh GK, Roeters van Lennep JE, Raal FJ, Blom DJ, Catapano AL. Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry , Eur Heart J: 2026

Schonck WA, Hovingh GK, Blom DJ, Tromp T, Cuchel M, Alnouri F, Raal FJ, Roeters van Lennep JE, Fahed AC, Catapano AL, Zwinderman AH, Stroes ESG, D'Erasmo L, Reeskamp LF; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry , Atherosclerosis, 415: 2026,120717

Ahmad Z, Agarwala A, Cuchel M, Barton Duell P, Hegele RA, Hudgins L, Jamison A, Kalra D, Khera A, Knowles JW, Kullo IJ, Morales A, Rothstein MA, Saseen JJ, Soffer DE, Warden BA, Weintraub WS, Williams L, Goldberg AC. Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association , J Clin Lipidol: 2026

Pang J, Gidding SS, Kelty E, Raal FJ, Cuchel M, Hudgins LC, Blom DJ, Sorial E, Russell DJ, Ramachandra D, Ademi Z, Watts GF. Liver transplantation in severe homozygous familial hypercholesterolaemia: a scoping review , Atherosclerosis: 2026

David Y. Zhang, Marylyn D. Ritchie, Daniel J. Rader, Marina Cuchel A loss-of-function missense variant in ANGPTL3 exerts protective effects against kidney disease risk , Atherosclerosis Supplement, 407: 2025,120322

Mulder JWCM, Reijman MD, Kusters DM, Boersma E, Alnouri F, Blom DJ, Catapano AL, Cuchel M, Dann EJ, Freiberger T, Groselj U, Harada-Shiba M, Hovingh GK, Iatan I, Ibarretxe D, Kayikcioglu M, Kim NT, Klingel R, Raal FJ, Reeskamp LF, Sadiq F, Schonck WAM, Tromp TR, Truong TH, Wiegman A, Roeters van Lennep JE; Homozygous Familial Hypercholesterolemia International Clinical Collaborators. Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era , J Am Coll Cardiol, 85: 2025,1898-1903

Arca M, D'Erasmo L, Cuchel M, J Blom D, Cegla J, Duell PB, Santos RD, O'Brien S. Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data , J Clin Lipidol: 2025

Marina Cuchel, MD, PhD